John David Hansen, PRESIDENT AND CEO at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), sold 118,526 shares at $0.92 ($109K) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Open-market sale of $109k MBVX by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.92 | 59,263 | $55K | 50.0% |
| 2 | $0.92 | 59,263 | $55K | 50.0% |
| Total | $0.92 avg | 118,526 | $109K | 100% |
| Filing → |
| MBVX | SELL | 2017-04-14 | $20K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $3K | — | Filing → |
| MBVX | SELL | 2017-04-06 | $11K | — | Filing → |